litlas
Log inCreate account

Robert Newton

Active 1986–2025

163
Papers
20,820
Citations
90
h-index
157
i10-index

Citations

Citations per year for Robert Newton1984: 1 citations1987: 1 citations1988: 2 citations1989: 7 citations1990: 13 citations1991: 19 citations1992: 15 citations1993: 22 citations1994: 10 citations1995: 27 citations1996: 28 citations1997: 59 citations1998: 102 citations1999: 147 citations2000: 232 citations2001: 198 citations2002: 199 citations2003: 209 citations2004: 184 citations2005: 198 citations2006: 160 citations2007: 189 citations2008: 225 citations2009: 192 citations2010: 164 citations2011: 177 citations2012: 176 citations2013: 149 citations2014: 149 citations2015: 147 citations2016: 116 citations2017: 163 citations2018: 144 citations2019: 472 citations2020: 507 citations2021: 498 citations2022: 401 citations2023: 299 citations2024: 409 citations2025: 195 citations2026: 4 citations1985–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,511 citing papers, 28.9% of this breakdownUnited Kingdom: 845 citing papers, 9.7% of this breakdownChina: 657 citing papers, 7.6% of this breakdownGermany: 430 citing papers, 5% of this breakdownItaly: 339 citing papers, 3.9% of this breakdownFrance: 317 citing papers, 3.7% of this breakdownCanada: 294 citing papers, 3.4% of this breakdownJapan: 272 citing papers, 3.1% of this breakdownAustralia: 244 citing papers, 2.8% of this breakdownSpain: 195 citing papers, 2.2% of this breakdownNetherlands: 156 citing papers, 1.8% of this breakdownSwitzerland: 153 citing papers, 1.8% of this breakdown
0%28.9%Other 26.1%

Institutions

Fields

  • Medicine60.1%
  • Biochemistry, Genetics and Molecular Biology19.5%
  • Immunology and Microbiology8.3%
  • Neuroscience7.2%
  • Computer Science0.8%
  • Chemistry0.7%
  • Other3.4%

Topics

  • Viral-associated cancers and disorders3.2%
  • Cancer Immunotherapy and Biomarkers2.5%
  • Immune Cell Function and Interaction2.2%
  • Tryptophan and brain disorders2%
  • Cytokine Signaling Pathways and Interactions1.9%
  • Asthma and respiratory diseases1.8%
  • Other86.4%

Coauthors

All papers

Open in search
  1. Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib

    Authors: Ian M. Silverman, Antoine Hollebecque, Luc Friboulet, Sherry Owens, Robert Newton, Hui‐Ling Zhen, Luis Féliz, Camilla Zecchetto, Davide Melisi, Timothy C. Burn - Cancer Discovery 2020 cited by 284

  2. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

    Authors: Xiangdong Liu, Niu Shin, Holly K. Koblish, Gengjie Yang, Qian Wang, Kathy Wang, Lynn Leffet, Michael Hansbury, Beth Ann Thomas, Mark Rupar, Paul Waeltz, Kevin Bowman, Padmaja Polam, Richard Sparks, Eddy W. Yue, Yanlong Li, Richard Wynn, Jordan S. Fridman, Timothy C. Burn, Andrew P. Combs, Robert Newton, Peggy Scherle - Blood 2010 cited by 559

  3. Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment

    Authors: Stefani Spranger, Holly K. Koblish, Brendan Horton, Peggy Scherle, Robert Newton, Thomas F. Gajewski - Journal for ImmunoTherapy of Cancer 2014 cited by 545

  4. First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies

    Authors: Gregory L. Beatty, Peter J. O’Dwyer, Jason Clark, Jack Shi, Kevin Bowman, Peggy Scherle, Robert Newton, Richard Schaub, Janet Maleski, Lance Leopold, Thomas F. Gajewski - Clinical Cancer Research 2017 cited by 318

  5. Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050

    Authors: Jordan S. Fridman, Peggy Scherle, Robert J. Collins, Timothy C. Burn, Yanlong Li, Jun Li, Maryanne Covington, Beth Ann Thomas, Paul Collier, Margaret Favata, Xiaoming Wen, Jack Shi, Ryan McGee, Patrick J. Haley, Stacey Shepard, James D. Rodgers, Swamy Yeleswaram, Greg Hollis, Robert Newton, Brian Metcalf, Steven Friedman, Kris Vaddi - The Journal of Immunology 2010 cited by 463

  6. Childhood cancer: Estimating regional and global incidence

    Authors: W. Thomas Johnston, Friederike Erdmann, Robert Newton, Eva Steliarova‐Foucher, Joachim Schüz, Eve Roman - Cancer Epidemiology 2020 cited by 194

  7. Burkitt's lymphoma

    Authors: Elizabeth Molyneux, Rosemary Rochford, Beverly E. Griffin, Robert Newton, Graham Jackson, Menon Geetha, Christine J. Harrison, Trijn Israëls, Simon Bailey - The Lancet 2012 cited by 604

  8. The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells

    Authors: Caroline Jochéms, Massimo Fantini, Romaine I. Fernando, Anna Kwilas, Renee N. Donahue, Lauren M. Lepone, Italia Grenga, Young‐Seung Kim, Martin W. Brechbiel, James L. Gulley, Ravi A. Madan, Christopher R. Heery, James W. Hodge, Robert Newton, Jeffrey Schlom, Kwong Y. Tsang - Oncotarget 2016 cited by 142

  9. Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study

    Authors: June Fabian, Robert Kalyesubula, Joseph Mkandawire, Christian Holm Hansen, Dorothea Nitsch, Eustasius Musenge, Wisdom P. Nakanga, Josephine E. Prynn, Gavin Dreyer, Tracy Snyman, Billy Ssebunnya, Michèle Ramsay, Liam Smeeth, Stephen Tollman, Saraladevi Naicker, Amelia C. Crampin, Robert Newton, Jaya A. George, Laurie A. Tomlinson, Louis Banda, Steven Bello, Keith Branson, Christina Chisambo, Odala Chithodwe, Charity Kanyenda, Cynthia Katundu, Noel Kayange, Marriot Kayolo, Veronica Kuchipanga, Dorothy Makoka Kyumba, Adrian Malunga, Beatson Mvula, Elisah Mweso, Efrida Mwiba, Lydia Ngwira, Lawrence Nkhwazi, Maureen Thindwa, Itayi Adams, K O Barrow, Claudia Beltramo, C Bouter, Geoffrey Candy, Shingirai Chipungu, Tafadzwa Chitagu, Phumzile Dlamini, Xavier Gomez Olive Casas, Mwawi Gondwe, Pearl Gumede, Chodziwadziwa Kabudula, Brenda Kagodora, Kathleen Kahn, Lungile Khambule, Bongekile Khoza, Dorcus Khoza, Simon Khoza, Weekend Khoza, Jonathan Levin, Dorcas Lesolang, Melody Mabuza, Heather Maher, Nontsikeleko Mahime, Willy Malupi, Gontse Maphatahanyi, Nonhlanhla Mashaba, Gift Mathebula, Busisiwe Mayindi, Brian Mdaka, Memory Mhembere, Mevian Mkansi, Rrhandzu Mnisi, Vusi Mnisi, Conrad Mogane, Tshepiso Mokoena, Walter Ndlovu, Zandy Ndlovu, Fortunate Ngobeni, Khanyisile Ngobeni, Nyiko Ngobeni, Tsakani Ngobeni, Ngoni Ngwarai, Doreen Nkuna, Median Ntimane, Terrence Ntimane, Obed Nxumalo, Daniel Ohene‐Kwofie, Florah Sihlangu, Bianca Silubane, Cassandra Claire Soo, Jeffrey Tibane, Rhian Twine, Surprise Ubisi, Mboyo-Di-Tamba Vangu, Alisha N. Wade, Floidy Wafawanaka, Gershim Asiki, Dominic Bukenya, Innocent Erone, Grace Tumwekase, Elizabeth Kabunga, Ayoub Kakande and 17 more - The Lancet Global Health 2022 cited by 89

  10. Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era

    Authors: Anthony N. Gerber, Robert Newton, Sarah K. Sasse - Journal of Biological Chemistry 2021 cited by 67

  11. A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3

    Authors: Xiangdong Liu, Qian Wang, Gengjie Yang, Cindy Marando, Holly K. Koblish, Leslie Hall, Jordan S. Fridman, Elham Behshad, Richard Wynn, Yu Li, Jason Boer, Sharon Diamond, Chunhong He, Meizhong Xu, Jin‐Cong Zhuo, Wenqing Yao, Robert Newton, Peggy Scherle - Clinical Cancer Research 2011 cited by 274

  12. A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis

    Authors: Robert Bissonnette, Monica Luchi, Rosanne Fidelus-Gort, Shawnta Jackson, Haifeng Zhang, Robert Flores, Robert Newton, Peggy Scherle, Swamy Yeleswaram, Xuejun Chen, Alan Menter - Journal of Dermatological Treatment 2016 cited by 84

  13. A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer

    Authors: Rebecca Kristeleit, Ірина Давиденко, Vadim Shirinkin, Fatima El-Khouly, Igor Bondarenko, Michael J. Goodheart, В. А. Горбунова, C A Penning, Jack Shi, Xiangdong Liu, Robert Newton, Yufan Zhao, Janet Maleski, Lance Leopold, Russell J. Schilder - Gynecologic Oncology 2017 cited by 101

  14. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

    Authors: Bin-Bing Zhou, Michael Peyton, Biao He, Changnian Liu, Luc Girard, Eian Caudler, Yvonne Lo, Frédéric Baribaud, Iwao Mikami, Noemı́ Reguart, Gengjie Yang, Yanlong Li, Wenqing Yao, Kris Vaddi, Adi F. Gazdar, Steven Friedman, David M. Jablons, Robert Newton, Jordan S. Fridman, John D. Minna, Peggy Scherle - Cancer Cell 2006 cited by 375

  15. Pediatric Malignancies, Treatment Outcomes and Abandonment of Pediatric Cancer Treatment in Zambia

    Authors: Jeremy S. Slone, Catherine Chunda‐Liyoka, Marta Sánchez Pérez, Nora Mutalima, Robert Newton, Chifumbe Chintu, Chipepo Kankasa, James Chipeta, Douglas C. Heimburger, Sten H. Vermund, Debra L. Friedman - PLoS ONE 2014 cited by 106

  16. Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases

    Authors: Maryanne Covington, Xin He, Monika Scuron, Jun Li, Robert J. Collins, Ashish Juvekar, Niu Shin, Margaret Favata, Karen Gallagher, Sarala Sarah, Chu‐Biao Xue, Michael T. Peel, Krista Burke, Julian Oliver, Brittany Fay, Wenqing Yao, Taisheng Huang, Peggy Scherle, Sharon Diamond, Robert Newton, Yan Zhang, Paul Smith - European Journal of Pharmacology 2020 cited by 47

  17. Usefulness of high‐risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta‐analysis

    Authors: Mwiza Gideon Singini, Elvira Singh, Debbie Bradshaw, Thendo Ramaliba, Wenlong Carl Chen, Melitah Motlhale, Abram Bunya Kamiza, Chantal Babb de Villiers, Mazvita Muchengeti, Christopher G. Mathew, Robert Newton, Noemi Bender, Tim Waterboer, Freddy Sitas - Journal of Medical Virology 2022 cited by 24

  18. Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor

    Authors: Lois Witters, Peggy Scherle, Steven Friedman, Jordan S. Fridman, Eian Caulder, Robert Newton, Allan Lipton - Cancer Research 2008 cited by 116

  19. Age patterns of HIV incidence in eastern and southern Africa: a modelling analysis of observational population-based cohort studies

    Authors: Kathryn Risher, Anne Cori, Georges Reniers, Milly Marston, Clara Calvert, Amelia C. Crampin, Tawanda Dadirai, Albert Dube, Simon Gregson, Kobus Herbst, Tom Lutalo, Louisa Moorhouse, Baltazar Mtenga, Dorean Nabukalu, Robert Newton, Alison Price, Malebogo Tlhajoane, Jim Todd, Keith Tomlin, Mark Urassa, Alain Vandormael, Christophe Fraser, Emma Slaymaker, Jeffrey W. Eaton - The Lancet HIV 2021 cited by 90

  20. Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis

    Authors: Anna McNaughton, José Lourenço, Phillip Armand Bester, Jolynne Mokaya, Sheila Lumley, Uri Obolski, Dónall Forde, Tongai Maponga, Kenneth Katumba, Dominique Goedhals, Sunetra Gupta, Janet Seeley, Robert Newton, Ponsiano Ocama, Philippa C. Matthews - PLoS Medicine 2020 cited by 77

  21. Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells

    Authors: Akanksha Bansal, Mahmoud Mostafa, Cora Kooi, Sarah K. Sasse, Aubrey N. Michi, Suharsh Shah, Richard Leigh, Anthony N. Gerber, Robert Newton - Journal of Biological Chemistry 2022 cited by 23

  22. Molecular mechanisms of glucocorticoid action: what is important?

    Authors: Robert Newton - Thorax 2000 cited by 513

  23. Cloning and Characterization of ADAMTS11 , an Aggrecanase from the ADAMTS Family

    Authors: Ilgar Abbaszade, Rui‐Qin Liu, Fude Yang, Stuart A. Rosenfeld, O.Harold Ross, John R. Link, Dawn M. Ellis, Micky D. Tortorella, Michael A. Pratta, Jeannine M. Hollis, Richard Wynn, Jodie L. Duke, Henry J. George, Milton C. Hillman, Kathleen Murphy, Barbara H. Wiswall, Robert A. Copeland, Carl P. Decicco, R. Brückner, Hideaki Nagase, Yoshifumi Itoh, Robert Newton, Ronald L. Magolda, James M. Trzăskos, Gregory Hollis, Elizabeth C. Arner, Timothy C. Burn - Journal of Biological Chemistry 1999 cited by 489

  24. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms

    Authors: Louise Donnelly, Robert Newton, Gina E. Kennedy, Peter Fenwick, Rachel H. F. Leung, Kazuhiro Ito, Richard Russell, Peter J. Barnes - American Journal of Physiology-Lung Cellular and Molecular Physiology 2004 cited by 360